{"filings":[{"id":442960,"accession_number":"0001628280-26-035124","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-05-14T20:16:55+00:00","items":["5.07"],"status":"ready","headline":"Kimberly-Clark elects all 13 directors; shareholder proposal for independent chair fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 13 management director nominees elected with votes ranging from 229.4M to 240.7M for each.","Ratification of Deloitte & Touche as 2026 auditor passed with 271.5M for vs 17.3M against.","Advisory vote on named executive officer compensation approved with 227.4M for, 14.6M against.","Stockholder proposal requiring an independent board chair defeated (81.7M for, 159.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98240,"accession_number":"0001628280-26-030566","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kimberly-Clark Controller Andrew Scribner to Depart; CFO Nelson Urdaneta to Assume Interim Role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Scribner, Vice President and Controller, notified of departure effective May 22, 2026 to pursue other opportunities.","Senior Vice President and CFO Nelson Urdaneta will serve as principal accounting officer on an interim basis starting May 22, 2026.","Mr. Urdaneta will continue his current CFO duties while assuming the additional interim controller responsibilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98239,"accession_number":"0001628280-26-027718","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 2026: Net sales $4.2B (+2.7%), adj. EPS attributable $1.97 (+2.1%), reaffirms 2026 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B, up 2.7% (organic +2.5%); volume/mix +3% offset by pricing -0.5%.","Adjusted EPS from continuing ops $1.60 (-1.2%) on higher tax rate; adjusted EPS attributable $1.97 (+2.1%) including discontinued ops.","Adjusted operating profit $732M (+3.7%) on productivity savings; GAAP gross margin 36.8%, adjusted 37.9% (-60bps).","Includes $120M insurance settlement benefit and $99M charges for Transformation & Kenvue acquisition costs.","Reaffirmed 2026 outlook; CEO cites momentum and Kenvue acquisition as 'generational value creation opportunity.'"],"consensus_eps_estimate":null,"consensus_eps_actual":2.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":4163000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113584,"accession_number":"0001104659-26-008005","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Kimberly-Clark and Kenvue shareholders overwhelmingly approve acquisition; deal expected H2 2026","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Approximately 96% of Kimberly-Clark shares present voted to approve share issuance related to the acquisition.","Approximately 99% of Kenvue shares voted to adopt merger agreement, representing ~77% of all outstanding shares.","Transaction expected to close in second half of 2026, subject to regulatory approvals and customary conditions.","Kimberly-Clark CEO cites milestone in creating global health and wellness leader; integration planning underway."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113583,"accession_number":"0001628280-26-003514","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-01-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"KMB reports Q4 adjusted EPS $1.86 (+24% YoY); organic sales +2.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $4.1B, down 0.6% (organic +2.1%); full-year adjusted EPS $7.53, up 3.2%.","Adjusted Q4 operating profit $629M, +13.1% YoY; adjusted gross margin 37.0% in line with prior year.","Personal Care segments: NA organic sales +0.8%, IPC +4.5% in Q4; volume-plus-mix driven growth.","Company announces acquisition of Kenvue as next step in transformation, citing strong integration progress."],"consensus_eps_estimate":null,"consensus_eps_actual":6.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":16447000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113582,"accession_number":"0001104659-26-004634","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-01-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Kimberly-Clark supplements proxy disclosures in response to stockholder lawsuits over Kenvue merger","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four lawsuits filed Dec 2025–Jan 2026 by Kenvue stockholders; one Delaware suit by K‑C stockholder.","Supplement adds details on strategic review committee formed June 30, 2025, and NDA terms with K‑C.","K‑C engaged Gibson Dunn for product liability due diligence; Kirkland disclosed Kenvue <1% of revenue.","J.P. Morgan expects ~$23.4M financing fees; aggregate fees from Kenvue $24M, from K‑C $11M.","Centerview updated DCF analysis implying K‑C equity value range of $119.14–$141.25 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129982,"accession_number":"0001628280-25-055209","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark recasts prior financials; filing truncated, lacks details","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Item 8.01 filed to recast certain annual report financial information and related disclosures.","XBRL tags indicate recast covers fiscal years 2022-2024, including 2024 Transformation Initiative and sale of KC Professional PPE business.","Segments noted: North America and International Personal Care; Thinx and Brazil tissue sale referenced.","Filing text cuts off mid-sentence; no specific recast numbers or reasons provided.","Investor should await complete filing for material impact of restated figures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129981,"accession_number":"0001628280-25-050635","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kimberly-Clark CDTO Zackery Hicks to depart March 31, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Zackery Hicks, Chief Digital and Technology Officer, will leave effective March 31, 2026 to pursue other opportunities.","Hicks will receive severance benefits consistent with the company's Severance Pay Plan.","No replacement or interim officer has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129980,"accession_number":"0001104659-25-105220","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Kimberly-Clark to acquire Kenvue in stock-and-cash deal; $7.7B bridge facility arranged","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Each Kenvue share to receive 0.14625 K-C shares + $3.50 cash; boards of both companies unanimously approved.","K-C secures $7.7B bridge loan commitment from JPMorgan to fund cash consideration and related expenses.","Termination fee of $1.136B payable under certain conditions; deal expected to close by Nov 2026 (possible extension to May 2027).","Post-closing, K-C Board will include three Kenvue designees; Kenvue equity awards converted to K-C awards.","Transaction subject to stockholder approvals, HSR and foreign antitrust clearances, and other customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129979,"accession_number":"0001628280-25-047278","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3: net sales $4.2B flat, organic +2.5%, adj EPS $1.82 in line, margin down 170bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B flat YoY; organic sales +2.5% on 2.4% volume growth.","Reported EPS $1.34; adjusted EPS $1.82 broadly in line with prior year.","Adjusted gross margin 36.8%, down 170bps due to tariff costs and price investments.","Effective tax rate on adjusted basis 26.5% vs 21.5% prior, impacted by OBBBA.","YTD organic sales +1.6%; adjusted EPS $5.67, down 2.2% including FX headwinds."],"consensus_eps_estimate":null,"consensus_eps_actual":4.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":12367000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146570,"accession_number":"0000055785-25-000076","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimb Q2 organic sales +3.9%; vol growth 5%; raised 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B, down 1.6% total; organic sales +3.9% on 5% volume growth, highest in 5 years.","Reported diluted EPS $1.53; adjusted EPS $1.92, down 2.0% YoY, including currency headwinds.","Adjusted gross margin 36.9%, down 180 bps due to pricing investments and tariff costs, offset by productivity.","Full-year 2025 outlook raised; management cites strong execution of Powering Care transformation.","Personal Care organic +3.3%, North America +4.3%, International Professional & Consumer +0.4%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":8217000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146569,"accession_number":"0000055785-25-000071","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Kimberly-Clark files supplemental financials for IFP joint venture with Suzano","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Suzano acquires 51% of IFP joint venture for ~$1.7B at closing; K-C retains 49%.","IFP Business reclassified as discontinued operations effective Q2 fiscal 2025.","Supplemental historical financials provided in Exhibit 99.1 to aid year-over-year comparisons.","No specific financial figures from the exhibit are available in this filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164949,"accession_number":"0001104659-25-056662","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Kimberly-Clark to sell 51% of IFP business to Suzano for ~$1.7B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["IFP contributed ~$3.3B net sales in 2024; 22 plants, ~9,000 employees, 70+ countries.","KMB retains 49% stake; Suzano gets call option on remaining stake under agreed framework.","Deal expected to close mid-2026; first-full-year diluted EPS by $0.30–0.40.","KMB expects to return net cash proceeds to shareholders via share repurchases.","Sharpen focus on higher-growth personal care and North America tissue categories."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164948,"accession_number":"0000055785-25-000051","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["3.01","5.03","7.01","9.01"],"status":"ready","headline":"Kimberly-Clark to transfer stock listing from NYSE to Nasdaq effective May 30, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Common stock to cease trading on NYSE at close on May 29, 2025; trading begins on Nasdaq Global Select on May 30, 2025 under symbol 'KMB'.","Board amended By-Laws to remove references to NYSE rules, effective upon Nasdaq listing.","Transfer is voluntary; ticker symbol KMB unchanged.","Forward-looking statements caution about risks of delays or market disruptions during transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164947,"accession_number":"0000055785-25-000044","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark promotes Russ Torres to President and COO, effective May 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Torres previously President, North America; now oversees day-to-day operations of all business segments and global functions.","Base salary $975,000, target bonus 125%, equity grants: 19,866 PSUs and 13,244 RSUs.","Kurt Laufer named Interim President, North America; permanent successor search underway.","Jeffrey Melucci elected Chief Strategy, Business Development and Administrative Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164944,"accession_number":"0000055785-25-000045","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K/A","filed_at":"2025-05-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Scribner receives 2,118 performance and 2,118 time-vested RSUs, $535K salary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Scribner's base salary set at $535,000 per year; effective June 1, 2025 as VP and Controller.","Target annual bonus of 55% of base salary under company performance-based incentive plan.","Long-term incentive award of 2,118 performance-based RSUs and 2,118 time-vested RSUs granted.","Eligible for supplemental 401(k) plan and other employee benefit plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164946,"accession_number":"0000055785-25-000041","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"All 13 Kimberly-Clark director nominees elected; Deloitte ratified; say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 13 management director nominees elected; Michael D. Hsu received 15.9M votes against (6% of votes cast).","Ratification of Deloitte & Touche as 2025 auditor passed with 267.2M for, 20.0M against (7% against).","Advisory vote on named executive officer compensation approved with 226.8M for, 17.4M against (7% against).","Broker non-votes of 41.9M shares on director elections and say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164945,"accession_number":"0000055785-25-000034","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 net sales $4.8B (-6.0%); adjusted EPS $1.93 (-4.0%); cuts full-year outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $4.8B, down 6.0% YoY; organic sales -1.6% (price -1.5%, volume/mix flat).","Adjusted EPS $1.93, down 4.0% vs prior year; reported EPS $1.70 includes $0.23 Transformation charges.","Adjusted gross margin 36.9%, down 20bps; adjusted operating profit $844M, down 6.0%.","Full-year 2025 outlook lowered to reflect potential incremental costs from geopolitical uncertainty.","Transformation Initiative charges in Q1: $75M ($0.23 EPS) vs $45M ($0.10) in prior year."],"consensus_eps_estimate":null,"consensus_eps_actual":1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":4840000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182662,"accession_number":"0000055785-25-000008","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kimberly-Clark names Andrew Scribner VP and Controller, replacing retiring Andrew Drexler","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Scribner elected VP and Controller, effective June 1, 2025; succeeds Andrew S. Drexler.","Drexler will assume a transitional role until retirement on June 6, 2025.","Scribner previously CFO of Kimberly-Clark North America since Jan 2023; prior roles at Gap Inc. and Kraft Heinz.","Compensation for Scribner's new role not yet determined; to be disclosed in an 8-K amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182661,"accession_number":"0000055785-25-000005","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q4 organic sales up 2.3%; FY 2024 adjusted EPS $7.30, up 11.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $4.9B (-0.8% total); organic sales grew 2.3% with volume up 1.5%.","Q4 adjusted EPS $1.50, down 0.7% YoY; FY 2024 adjusted EPS $7.30, up 11.1%.","Q4 adjusted gross margin 35.4% (+50 bps); FY adjusted gross margin 36.5% (+200 bps).","FY 2024 adjusted operating profit $3.2B, up 9.4% YoY despite 6.2 ppt currency headwind.","2025 outlook reflects continued organic growth and operating momentum as transformation progresses."],"consensus_eps_estimate":null,"consensus_eps_actual":7.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":20058000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199237,"accession_number":"0000055785-24-000107","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark reorganizes reportable segments effective Q4 2024; provides recast historical data","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New segments: North America (NA), International Personal Care (IPC), and International Family Care and Professional (IFP).","Replaces former segments: Personal Care, Consumer Tissue, and K-C Professional.","Supplemental recast financials provided for quarters back to Q1 2023 and years 2021-2023.","Segment profitability measure now includes effects of highly inflationary currency adjustments.","No impact on consolidated financial results; change improves supply chain and overhead efficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199236,"accession_number":"0000055785-24-000098","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark elects Joseph Romanelli to board of directors, effective immediately","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Romanelli, 51, appointed as independent director and to the Audit Committee; board expands from 12 to 13 members.","He serves as President of Human Health International for Merck & Co., Inc. (MSD).","Romanelli brings global leadership experience in biopharmaceuticals and international markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199235,"accession_number":"0000055785-24-000091","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3 adj. EPS $1.83 (+5%), organic sales +1%, net sales down 4% on FX and divestitures","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $5.0B (-4% reported); organic sales +1% (price +1%, volume/mix flat).","Adjusted EPS $1.83 (+5% YoY) with $0.07 FX headwind; GAAP EPS $2.69 includes $1.34 gain from PPE divestiture.","Adjusted operating profit +5%; adjusted gross margin 36.7% (+90 bps) on productivity.","Personal Care organic +3%, Consumer Tissue -1%, K-C Professional -1% (organic).","2024 outlook: organic sales growth revised to 3%-4% (from mid-single digit); profit outlook reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":6.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":15130000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215274,"accession_number":"0000055785-24-000081","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q2 adj EPS $1.96 (+19% YoY); raises 2024 profit outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $5.0B (organic +4%), reported EPS $1.61, adjusted EPS $1.96 up 19%.","Adjusted operating profit +16%; adjusted gross margin 36.9% (+290 bps YoY).","Personal Care organic +8% (North America +5%, D&E +15%), Consumer Tissue -2%, KCP flat.","2024 outlook raised: adj operating profit and EPS now expected mid-to-high teens constant-currency growth (from low-teens).","YTD operating cash flow $1.5B, returned $965M via dividends and buybacks."],"consensus_eps_estimate":null,"consensus_eps_actual":3.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":10178000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234589,"accession_number":"0000055785-24-000059","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Kimberly-Clark shareholders approve charter amendment limiting officer liability","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved Amended and Restated Certificate of Incorporation to limit personal liability of certain officers for breaches of fiduciary duty of care (not loyalty).","All 12 director nominees elected; Deloitte & Touche ratified as independent auditor for 2024.","Advisory vote on executive compensation approved: ~221.7M for, ~23.5M against.","Charter amendment also includes technical changes; effective May 2, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234588,"accession_number":"0000055785-24-000053","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 adj EPS $2.01 (+20% YoY); raises FY2024 organic sales and EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $5.1B, organic +6% driven by price (+4%), volume (+1%), mix (+1%).","Gross margin 37.1%, up 390 bps YoY.","Adj EPS $2.01, up 20% YoY; includes $0.21 FX headwind.","Raises 2024 outlook: organic sales now mid-single digits (prev low-to-mid), adj EPS growth low-teens (prev high-single).","Personal Care organic +10%, Consumer Tissue flat, KCP organic +2%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":5149000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}